AlphaFold predicted structure
LFNG · Q8NES3

Mean pLDDT
82.2/ 100
Confident
379 residues
Confidence breakdown
- Very high(≥ 90)65%
- Confident(70–90)13%
- Low(50–70)7%
- Very low(< 50)15%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
Congenital disorders of glycosylation
BIALLELIC, autosomal or pseudoautosomalDDG2P
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalLikely inborn error of metabolism
BIALLELIC, autosomal or pseudoautosomalSkeletal dysplasia
BIALLELIC, autosomal or pseudoautosomalFamilial Neural Tube Defects
BIALLELIC, autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomalMonogenic hearing loss
+1 more panels — install the extension to see the full list inline on any page.
autosomal recessive spondylocostal dysostosis
hypertensive disorder
cardiovascular disorder
spondylocostal dysostosis
neurodegenerative disease
Increased blood pressure
benign prostatic hyperplasia
cardiac arrest
heart conduction disease
essential hypertension
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Beta-1,3-N-acetylglucosaminyltransferase lunatic fringe
Glycosyltransferase that initiates the elongation of O-linked fucose residues attached to EGF-like repeats in the extracellular domain of Notch molecules. Modulates NOTCH1 activity by modifying O-fucose residues at specific EGF-like domains resulting in inhibition of NOTCH1 activation by JAG1 and enhancement of NOTCH1 activation by DLL1 via an increase in its binding to DLL1 (By similarity). Decreases the binding of JAG1 to NOTCH2 but not that of DLL1 (PubMed:11346656). Essential mediator of somite segmentation and patterning (By similarity)
LFNG · Q8NES3

Mean pLDDT
82.2/ 100
Confident
379 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0